Detalhe da pesquisa
1.
An inherited life-threatening arrhythmia model established by screening randomly mutagenized mice.
Proc Natl Acad Sci U S A
; 121(17): e2218204121, 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38621141
2.
Early Detection and Prediction of Anthracycline-Induced Cardiotoxicityã- A Prospective Cohort Study.
Circ J
; 88(5): 751-759, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38462534
3.
Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation for Patients with Cancer: A Meta-Analysis.
Ann Surg Oncol
; 30(2): 711-721, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36273057
4.
Balloon surface temperature-controlled ablation using a second-generation radiofrequency HotBalloon: an in vivo feasibility study.
Europace
; 25(12)2023 12 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37950630
5.
Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation.
Clin Sci (Lond)
; 136(24): 1831-1849, 2022 12 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36540030
6.
Sodium Glucose Co-Transporter 2 Inhibitors Improve Renal Congestion and Left Ventricular Fibrosis in Rats With Hypertensive Heart Failure.
Circ J
; 86(12): 2029-2039, 2022 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-35944977
7.
Right bundle branch block and risk of cardiovascular mortality: the Ibaraki Prefectural Health Study.
Heart Vessels
; 37(4): 609-618, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34562143
8.
Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
Eur Heart J
; 42(29): 2854-2863, 2021 07 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34219138
9.
Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
Clin Sci (Lond)
; 135(20): 2409-2422, 2021 10 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34386810
10.
Correction: Feng et al. Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway. Int. J. Mol. Sci. 2020, 21, 4655.
Int J Mol Sci
; 22(19)2021 Oct 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34639240
11.
Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice.
Int J Mol Sci
; 22(3)2021 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33572655
12.
Neutrophil Elastase Deficiency Ameliorates Myocardial Injury Post Myocardial Infarction in Mice.
Int J Mol Sci
; 22(2)2021 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33450865
13.
MAIR-II deficiency ameliorates cardiac remodelling post-myocardial infarction by suppressing TLR9-mediated macrophage activation.
J Cell Mol Med
; 24(24): 14481-14490, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33140535
14.
Improved Risk Stratification of Patients With Brugada Syndrome by the New Japanese Circulation Society Guidelineã- A Multicenter Validation Study.
Circ J
; 84(12): 2158-2165, 2020 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33071242
15.
Cardiology consultation in oncology practice: a 5-year survey.
Jpn J Clin Oncol
; 50(12): 1419-1425, 2020 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32676637
16.
Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway.
Int J Mol Sci
; 21(13)2020 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32629939
17.
ASO Visual Abstract: Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation in Patients with Cancer: A Meta-analysis.
Ann Surg Oncol
; 30(2): 723-724, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36396872
18.
Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
J Card Fail
; 24(1): 53-60, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28888840
19.
Clinical Manifestations and Long-Term Mortality in Lamin A/C Mutation Carriers From a Japanese Multicenter Registry.
Circ J
; 82(11): 2707-2714, 2018 10 25.
Artigo
Inglês
| MEDLINE | ID: mdl-30078822
20.
Fragmented QRS Is a Novel Risk Factor for Ventricular Arrhythmic Events After Receiving Cardiac Resynchronization Therapy in Nonischemic Cardiomyopathy.
J Cardiovasc Electrophysiol
; 28(3): 327-335, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27925329